BIA
HAE icon

Beacon Investment Advisors’s Haemonetics HAE Stock Holding History

Beacon Investment Advisors’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.78M Hold
37,115
– – 0.87% 27
2026
Q1 		$2.09M Buy
37,115
+5,253
+16% +$342K 0.79% 32
2025
Q4 		$2.55M Buy
31,862
+138
+0.4% +$9.27K 1.02% 28
2025
Q3 		$1.55M Buy
31,724
+954
+3% +$59.1K 0.63% 50
2025
Q2 		$2.27M Buy
30,770
+50
+0.2% +$3.31K 0.98% 27
2025
Q1 		$1.95M Buy
30,720
+18,086
+143% +$1.23M 0.92% 29
2024
Q4 		$987K Buy
12,634
+87
+0.7% +$6.99K 0.46% 65
2024
Q3 		$1.01M Buy
12,547
+385
+3% +$31.1K 0.48% 63
2024
Q2 		$1.01M Buy
12,162
+30
+0.2% +$2.64K 0.51% 60
2024
Q1 		$1.04M Buy
12,132
+75
+0.6% +$5.89K 0.59% 54
2023
Q4 		$1.03M Hold
12,057
– – 0.66% 45
2023
Q3 		$1.08M Sell
12,057
-15
-0.1% -$1.34K 0.76% 44
2023
Q2 		$1.03M Sell
12,072
-295
-2% -$24.9K 0.7% 45
2023
Q1 		$1.02M Buy
12,367
+132
+1% +$10.7K 0.75% 43
2022
Q4 		$962K Buy
+12,235
New +$983K 0.8% 42

Other funds holding HAE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Beacon Investment Advisors's HAE Position: Q2 2026 in Review

Beacon Investment Advisors held its Haemonetics (HAE) position steady in Q2 2026 at 37,115 shares worth $2.78M. The position accounts for 0.87% of the portfolio, ranked #27.

Beacon Investment Advisors first reported a position in HAE in Q4 2022 and has held it in 15 quarters since. 329 funds tracked by Wall St. Rank hold HAE as of Q2 2026.

  • Beacon Investment Advisors held 37,115 shares of Haemonetics worth $2.78M as of Q2 2026.
  • Beacon Investment Advisors left its Haemonetics share count unchanged in Q2 2026.
  • Haemonetics made up 0.87% of Beacon Investment Advisors's portfolio in Q2 2026, its #27 holding.
  • Beacon Investment Advisors first reported a position in Haemonetics in Q4 2022 and has held it in 15 quarters since.
  • 329 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.

Based on Beacon Investment Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.